Neuroblastoma Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Neuroblastoma
| Protocol | COG ANBL2131 |
|---|---|
| Cancer Type: | Neuroblastoma |
| Fast Facts |
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
patients must be ≤ 30 years at the time of initial diagnosis with high-risk disease
Please check out the rare protocol list to locate other studies within this disease site.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
